Antiarrhythmics Flashcards
Outline the Vaughan Williams classification of antiarrhythmic drugs
CLASS 1: Na+ channel blockers
- Lidocaine (1B)*
- Flecainide (1C)*
CLASS 2: Beta blockers
- Bisoprolol*
- Metoprolol*
CLASS 3: K+ channel blockers
- Amiodarone*
- Sotolol*
CLASS 4: Ca2+ channel blockers
- Diltiazem*
- Verapamil*
CLASS 5: others
- Adenosine*
- Digoxin*
- Atropine*
- Ivabradine*
What is torsades de pointes?
Torsades de pointes is a specific form of polymorphic ventricular tachycardia in patients with a long QT interval. It is characterized by rapid, irregular QRS complexes
How is the coordination of a heart beat achieved?
Coordinated sequence of changes in membrane potentials; initiated in the SA node
Briefly describe how arrhythmias arise
Heart condition due to disturbances in:
- Pacemaker impulse generation (SA or AV node)
- Contraction impulse conduction (abnormal conduction through tissue)
- Combination of the two
Results in rate/timing of contraction of the heart muscle being _insufficient to maintain the normal CO_
Describe the generation of the resting membrane potential
- Transmembrane potential maintained; interior of cell -ve with respect to outside the cell
- Caused by unequal distribution of ions inside vs outside a cell
- Maintenance by ion selective channels, active pumps, exchangers
Via passive diffusion, ligand-gated ion channels, voltage-gated eg Ca2+ channels
Where does the fast cardiac action potential exist?
Cardiac tissue
Role of Na+/K+ ATP ase in restarting the action potential once reverted back to resting state
Describe the effects of Class 1 drugs (blocking Na+ channels)
C1: Na+ channel blockers
(Flecainide; used in AF, narrow complex tachycardias)
- Slowing conduction in cardiac tissue (phase 0)
- Minor effects on action potential duration (APD)
- Phase 0 (upright phase) shifted to right
Describe the effects of Class 2 drugs (B-blockers)
- Diminish phase 4 depolarisation and automaticity (any automatic or focal arrhythmias)
- Inhibit Ca2+ inflow into the heart, thus affect the plateau
Give some other ways by which B-blockers have antiarrhythmic effects
- Reducing HR
- Reducing AV conduction velocity
- Reducing delayed/early afterdepolarisations
- Reducing conduction velocity
- Reduce action potential duration (APD)
- Reduce effective refractory period (ERP)
- Reduce re-entry
Describe the effects of Class 3 drugs (K+ channel blockers)
- Increase action potential duration (APD)
- Increase refractory period
Increased refractory period leads to an extended QT interval- can lead to proarrhythmias/dangerous arrhythmias
Potassium Channel Blockers. A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS
Mechanism of Class 3 drugs
K+ channel blockers (Class 3)
Describe the effects of Class 4 drugs (Ca2+ channel blockers)
- Decrease inward Ca2+ currents
- Resulting in decreased phase 4 spontaneous depolarisation
- Affect the plateau phase of action potential
Where does the slow cardiac action potential occur?
SA and AV node (pacemaker potential)
Upstroke due to Ca2+ NOT Na+!
Describe the effect of Ca2+ channel blockers on the slow cardiac action potential
- Reduce conduction velocity (slope of phase 0 = CV)
- Slowing SA and AV node conduction velocity
- Increase refractory period
Mechanism of Ca2+ channel blockers on slow cardiac AP
Give some examples of drugs affecting the automaticity of the SLOW cardiac AP
B-agonist (eg salbutamol) - leads to sinus tachycardia (affecting SA node thus in sinus rhythm)
B-agonists increase the slope of the pacemaker potential (stimulation of sympathetic activity)
Muscarinic agonists (eg ADENOSINE) - affects slope of AP
Muscarinic agonists decrease the slope of the pacemaker potential (stimulation of parasympathetic activity)
REMEMBER
Fast AP in CARDIAC TISSUE
Slow AP in SA or AV node
Give the 2 main mechanisms of arrhythmogenesis
- Abnormal impulse generation (automatic rhythms)
- Abnormal conduction - re-entry
Explain the pathophysiology of Wolf-Parkinson-White syndrome
- Presence of an accessory pathway (Bundle of Kent); connects the atrium + ventricle
- Impluses are allowed to travel back up to the atrium, generating a re-entry loop
- WOLK-PARKINSON-WHITE SYNDROME: in small population, congenital abnormality
- Leads to pre-excitation
Treatment: catheter ablation to destroy accessory pathway (in high risk pt’s)